Pharmacology News and Research

Latest Pharmacology News and Research

PSI-developed drug could increase survival chances for metastatic prostate cancer patients

Researchers at PSI have developed a new drug that could increase the survival chances of patients with metastatic prostate cancer.

4 Jul 2023

Duke researchers expand functionality of CRISPR gene editing

CRISPR gene editing is a breakthrough that has been used to treat diseases such as sickle cell anemia, leukemia and genetic disorders, but it has challenges that limit its broad utility.

29 Jun 2023

MDXX drugs: A promising new therapy for autism spectrum disorder

A new review in the peer-reviewed journal Psychedelic Medicine describes the complex pharmacology of methylenedioxy amphetamine analogs, or MDXX drugs, and how they may help treat autism spectrum disorder (ASD).

29 Jun 2023

$9.8 million NCI grant aims to combat cancer disparities

Weill Cornell Medicine and Columbia University have been awarded a $9.8 million, five-year grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to help combat cancer disparities fueled by persistent poverty.

26 Jun 2023

New platform technology bridges the gap between microscopic analysis and multiplex imaging

Researchers at the Ludwig Center at Harvard have developed a platform technology for imaging that enables integration of the methods of microscopic analysis long employed in pathology laboratories with the visualization of multiple molecular markers in individual cells that is now rapidly advancing in research labs.

22 Jun 2023

Feeling high associated with improved symptom relief but increased negative side effects in medical cannabis patients

In a new study titled, "Understanding Feeling 'High' and Its Role in Medical Cannabis Patient Outcomes," published in the journal, Frontiers in Pharmacology, researchers at The University of New Mexico, in collaboration with Releaf App™ found that patients who reported feeling "High" experienced 7.7% greater symptom relief and an increase in reporting of positive side effects such as "Relaxed" and "Peaceful."

22 Jun 2023

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.

21 Jun 2023

Research explains mechanisms behind anti-viral protection in hemochorial placentas

Give credit to your dad's gene for keeping you safe during those long months in your mother's womb.

20 Jun 2023

MSU and Corewell Health researchers team up to study the health effects of lead poisoning

Researchers with Michigan State University and Corewell Health are partnering to study the health effects of lead poisoning in the Grand Rapids area where about one in 10 children has elevated lead levels in their blood, according to state data.

16 Jun 2023

KU investigator develops treatment for stroke, heart disease, other metabolic diseases

An investigator with the University of Kansas School of Pharmacy has filed an invention disclosure, part of a provisional patent application with the United States Patent and Trademark Office, for a treatment that could apply to heart disease, stroke and a host of other human diseases related to metabolism.

15 Jun 2023

$Study: Hip fracture cases estimated to nearly double by 2050$

Study: Hip fracture cases estimated to nearly double by 2050

An international group of researchers led by the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), and including Douglas P Kiel, MD, MPH, Director Musculoskeletal Research Center, Marcus Institute for Aging Research, Hebrew SeniorLife, and Professor of Medicine, Harvard Medical School, evaluated the secular trends in hip fracture incidence, treatment patterns following a hip fracture, and all-cause mortality in 19 countries and regions from 2005 to 2018.

15 Jun 2023

'Concerning' CT findings may be an important barrier to discharge of low-risk pulmonary embolism patients

Of approximately 250,000 Americans diagnosed with acute pulmonary embolism, or PE, in emergency departments each year, most are hospitalized.

15 Jun 2023

Measuring the receipt of medications and behavioral health services for AUD

Heavy drinking commonly begins in adolescence and is a known risk factor for the development of alcohol use disorder (AUD). Data from adult clinical trials suggest offering evidence-based medications for AUD to younger adults could promote their engagement in treatment and improve clinical outcomes.

15 Jun 2023

Strongest genetic risk factors for Viking disease are inherited from Neanderthals

Many men in northern Europe over the age of 60 suffer from the so-called Viking disease, which means that the fingers lock in a bent position.

14 Jun 2023

Molecule found in the venomous toadfish controls lung inflammation in mice

A molecule found in the venomous toadfish Thalassophryne nattereri has proved capable of controlling lung inflammation and could be the basis for a more effective asthma drug.

13 Jun 2023

Metrion Biosciences appoints Dr Steve Jenkinson as VP, Drug Discovery and Safety Assessment to strengthen US operations

Metrion Biosciences Ltd (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of Dr. Steve Jenkinson as Vice President, Drug Discovery and Safety Assessment. The US-based appointment represents an important step in the expansion of Metrion’s business, driven by its ion channel discovery capabilities.

From Metrion Biosciences Limited 12 Jun 2023

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

A clinical trial led by Yale Cancer Center shows that the drug osimertinib, a targeted therapy for non-small cell lung cancer, improved rates of survival and reduced risk of recurrence in patients after surgery.

7 Jun 2023

Diabetes drug reduces alcohol drinking by more than half in rats

The medication semaglutide, which is currently used in the treatment of type 2 diabetes and obesity, might also be an effective medication for alcohol dependence.

7 Jun 2023

How does tirzepatide stimulate insulin secretion?

Tirzepatide, a drug approved for diabetes and on the fast track for approval as a weight loss therapy, works through a unique ability to activate two different mechanisms the body uses to control insulin secretion and energy balance, Duke Health researchers report.

6 Jun 2023

Study unlocks insights into how 'good fat' tissue could be harnessed to combat obesity, diabetes

New research has unlocked insights into how "good fat" tissue could potentially be harnessed to combat obesity and remove glucose from the blood, helping to control diabetes.

31 May 2023

Pharmacology News and Research

Latest Pharmacology News and Research

PSI-developed drug could increase survival chances for metastatic prostate cancer patients

Duke researchers expand functionality of CRISPR gene editing

MDXX drugs: A promising new therapy for autism spectrum disorder

$9.8 million NCI grant aims to combat cancer disparities

New platform technology bridges the gap between microscopic analysis and multiplex imaging

Feeling high associated with improved symptom relief but increased negative side effects in medical cannabis patients

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

Research explains mechanisms behind anti-viral protection in hemochorial placentas

MSU and Corewell Health researchers team up to study the health effects of lead poisoning

KU investigator develops treatment for stroke, heart disease, other metabolic diseases

Study: Hip fracture cases estimated to nearly double by 2050

'Concerning' CT findings may be an important barrier to discharge of low-risk pulmonary embolism patients

Measuring the receipt of medications and behavioral health services for AUD

Strongest genetic risk factors for Viking disease are inherited from Neanderthals

Molecule found in the venomous toadfish controls lung inflammation in mice

Metrion Biosciences appoints Dr Steve Jenkinson as VP, Drug Discovery and Safety Assessment to strengthen US operations

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

Diabetes drug reduces alcohol drinking by more than half in rats

How does tirzepatide stimulate insulin secretion?

Study unlocks insights into how 'good fat' tissue could be harnessed to combat obesity, diabetes

Pittcon Highlights: Pharmaceutical & Biologic eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pharmacology News and Research

Latest Pharmacology News and Research

Pittcon Highlights: Pharmaceutical & Biologic eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in